Henry R. Kravis, 10% Owner at BridgeBio Pharma, Inc. (BBIO), sold 12,000,000 shares at $34.20 ($410.4M) on 2025-05-12, disclosed to the SEC on 2025-05-14.
Open-market sale of $410.4M BBIO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.20 | 6,000,000 | $205.2M | 50.0% |
| 2 | $34.20 | 6,000,000 | $205.2M | 50.0% |
| Total | $34.20 avg | 12,000,000 | $410.4M | 100% |
| Filing → |
| APP | SELL | 2024-11-25 | $3.3B | — | Filing → |
| APP | SELL | 2023-08-16 | $370.0M | — | Filing → |
| KKR | SELL | 2021-11-05 | $767.7M | — | Filing → |